As of Mar 23
| +0.30 / +1.29%|
The 7 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 29.00, with a high estimate of 31.00 and a low estimate of 19.00. The median estimate represents a +22.88% increase from the last price of 23.60.
The current consensus among 7 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.